HP
BNTX icon

Havemeyer Place’s BioNTech BNTX Stock Holding History

Havemeyer Place’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.89M Buy
20,283
+12,130
+149% +$1.14M 0.19% 186
2026
Q1 		$725K Buy
8,153
+1,239
+18% +$127K 0.08% 359
2025
Q4 		$658K Buy
+6,914
New +$697K 0.13% 280

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Havemeyer Place's BNTX Position: Q2 2026 in Review

Havemeyer Place increased its BioNTech (BNTX) stake by 149% in Q2 2026, buying an estimated $1.14M and bringing the position to 20,283 shares worth $1.89M. The position accounts for 0.19% of the portfolio, ranked #186.

Havemeyer Place first reported a position in BNTX in Q4 2025 and has held it in 3 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Havemeyer Place held 20,283 shares of BioNTech worth $1.89M as of Q2 2026.
  • Havemeyer Place bought 12,130 BioNTech shares in Q2 2026, an estimated $1.14M.
  • BioNTech made up 0.19% of Havemeyer Place's portfolio in Q2 2026, its #186 holding.
  • Havemeyer Place first reported a position in BioNTech in Q4 2025 and has held it in 3 quarters since.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Havemeyer Place's 13F filing for Q2 2026, filed 13 Aug 2026.